Neuraminidase as a novel therapeutic management strategy for Alzheimer's disease: evidenced through molecular docking, molecular dynamic simulation and gene expression analysis. [PDF]
Alzarea SI +7 more
europepmc +1 more source
Chronology of H3N2 human influenza virus surface glycoprotein adaptation from 1968 to 2019 reveals a surge of adaptation between 1997 and 2002. [PDF]
Lei H +9 more
europepmc +1 more source
Development of a multiplex and universal RT-PCR assay for hemagglutinin and neuraminidase subtyping of avian influenza virus. [PDF]
An SH, Heo GB, Kang YM, Lee YJ, Lee KN.
europepmc +1 more source
Identification of novel neuraminidase 1 modulators as potential therapeutics for Alzheimer's disease using virtual screening and molecular dynamics simulations. [PDF]
Alzarea SI.
europepmc +1 more source
Neurovascular pericytes are susceptible to infection by JC polyomavirus. [PDF]
O'Hara BA +4 more
europepmc +1 more source
[Orthomyxovirus neuraminidase].
E S, Isaeva, M I, Sokolov
openaire +1 more source
Antibacterial and antiviral potential of harmalacidine hydrochloride, a β-carboline alkaloid, against respiratory tract pathogens: Staphylococcus aureus and H1N1 influenza virus. [PDF]
Alossaimi MA +3 more
europepmc +1 more source
Structure-guided loop grafting improves expression and stability of influenza neuraminidase for vaccine development. [PDF]
Rijal P +7 more
europepmc +1 more source
Mapping the Global Antigenic Evolution of Human Influenza A/H3N2 Neuraminidase Based on a Machine Learning Model - 1968-2024. [PDF]
Feng J +7 more
europepmc +1 more source
Comprehensive evaluation of therapeutic effectiveness and safety profiles of baloxavir marboxil for managing influenza virus infection in pediatric populations: a systematic review with pooled meta-analytic data. [PDF]
Ji Y, Yang W, Wang W.
europepmc +1 more source

